Tag: TRUS biopsy

New tools like biomarker tests and 3T mpMRI are transforming how doctors evaluate a high PSA. Learn how these innovations reduce unnecessary prostate biopsies—saving patients from risk, stress, and costs—while delivering greater clarity in prostate cancer diagnosis. keep reading

In the world of prostate cancer (PCa), there is a dangerous cell pattern called cribriform (pronounced crib’ ri-form) or simply Cr. It has a distinctive appearance that looks similar to a sieve or a plate with lots of holes. Cr is associated with aggressive Gleason grade 4 cancer. Also, there is another PCa type called keep reading

Combining multiparametric MRI with genomic testing is revolutionizing prostate cancer detection and treatment. By leveraging the strengths of both technologies, doctors can achieve more accurate diagnoses, guide personalized treatment decisions, and improve patient outcomes. Learn how these tools are shaping the future of prostate cancer care. keep reading

“Out of all the stars labeled Box Office Poison by the Independent Theater Owners Association in 1938, Katharine Hepburn is one who maintains a high degree of name recognition today…” This is the opening sentence of a January 2023 article in Hollywood Revue, explaining how the Great Kate was dealt a blow to her reputation—a keep reading

Does PSA screening reduce PCa mortality, or doesn’t it? We know that PSA is not specific for cancer, since many prostate conditions can cause a rise in PSA blood levels. We also know that an elevated PSA can lead to a conventional TRUS-guided biopsy, and that such biopsies can either miss prostate cancer or... keep reading

When it comes to prostate cancer, your body comes equipped with a kind of check engine light. It’s your PSA blood test. If it comes back abnormally high or rising, it’s a physical uh-oh. Like a check engine light, it doesn’t tell you exactly what the problem is. A doctor’s next step might well be a conventional 12+ core, with its risks of inaccuracy and side effects. What if there were a simpler way to assemble and evaluate vital information in a single step, such as a blood draw? keep reading

Many symptoms, diseases or injuries are so clear-cut that diagnosing them is a no brainer. The body’s problem gives clear information and no guesswork is involved. Whether it’s a painful shingles rash, a rapidly swelling sprained ankle, or sudden crushing chest pain, a visit to your doctor or Emergency Department results in a rapid assessment, keep reading

“For the last 40 years the prostate’s been unusual in that we’ve been interrogating men who were at risk of prostate cancer with a random needle deployment of the organ, which we don’t do in any other organ systems in relation to cancer. I think we always knew it was unreliable, and that the diagnosis was uncertain, but I think we just didn’t realize... keep reading

One of the most exciting gatherings of medical minds is the Annual Congress of the European Association of Urology (EAU). Urology Today describes it as “Europe’s biggest urological event with specialists and affiliated medical professionals gathering for a critical assessment of clinical practices and key research developments..." keep reading

The Prostate MRI Imaging Study (PROMIS) was a landmark event in terms of demonstrating the superiority of multiparametric MRI (mpMRI) for biopsy guidance vs. conventional TRUS (transrectal ultrasound) guidance. Within a few years, more studies began to appear regarding biparametric MRI (bpMRI)... keep reading